World Tuberculosis Day 2018: Contribute to End TB
Tuberculosis (TB) is one of the leading causes of death worldwide; according to the World Health Organization, 104 million people fell ill with TB in 2016, and 1.7 million died from the disease. TB is curable and there is a vaccine available, but with increasing threat from multidrug-resistant strains of the bacterium that causes TB, Mycobacterium tuberculosis, researchers are working hard to develop more effective treatments and prevention measures.
On 24 March 2018, World TB Day calls for an end to TB. The annual event marks the date in 1882 when Dr. Robert Koch discovered M. tuberculosis as the cause of TB. This year’s theme – “Wanted: Leaders for a TB-free world” – encourages commitment from politicians, community leaders, civil society advocates, health workers, NGOs and those affected by TB to end the disease.
Researchers around the world are working hard to develop more effective treatments and prevention measures. In this collection, you can read recent research on TB – the causative bacterium, the disease, its prevention and cure – published in a range of Elsevier’s journals. The articles are free to access until he 24th of June 2018.
Clinical Microbiology and Infection
Phenotypic and genotypic characterization of pyrazinamide resistance among
Liu W, Chen J, Shen Y, Jin J, Wu J, Sun F, Wu Y, Xie L, Zhang Y, Zhang W.
Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review
Papaventsis D, Casali N, Kontsevaya I, Drobniewski F, Cirillo DM, Nikolayevskyy V.
Trends and differences in tuberculosis incidences and clustering among natives in Denmark, Sweden and Finland: comparison of native incidences and molecular epidemiology among three low-incidence countries
Pedersen MK, Lillebaek T, Andersen AB, Soini H, Haanperä M, Groenheit R, Jonsson J, Svensson E.
International Journal of Infectious Diseases
Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil
Moreira J, Castro R, Lamas C, Ribeiro S, Grinsztejn B, Veloso VG.
Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
Lee H, Ahn S, Hwang NY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Koh WJ
Ending the Global Tuberculosis Epidemic by 2030 - The Moscow Declaration and achieving a Major Translational Change in Delivery of TB Healthcare
Petersen E, Blumberg L, Wilson ME, Zumla A
Urine Colorimetry for Therapeutic Drug Monitoring of Pyrazinamide during Tuberculosis Treatment
Zentner I, Modongo C, Zetola NM, Pasipanodya JG, Srivastava S, Heysell SK, Mpagama S, Schlect HP, Gumbo T, Bisson GP, Vinnard C
Video Directly Observed Therapy to support adherence with treatment for tuberculosis in Vietnam: A prospective cohort study
Nguyen TA, Pham MT, Nguyen TL, Nguyen VN, Pham DC, Nguyen BH, Fox GJ
Journal of Infection
Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples
Zetola, Nicola M.; Modongo, Chawangwa; Matsiri, Ogopotse; et al.
Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease
Won, Eun-Jeong; Choi, Jung-Ho; Cho, Young-Nan; et al.
Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review
Pang, Yu; Lu, Jie; Huo, Fengmin; et al.
Travel Medicine and Infectious Disease
Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe
Matteelli A, Centis R, Sulis G, Tadolini M
Federal travel restrictions to prevent disease transmission in the United States: An analysis of requested travel restrictions
Jungerman MR, Vonnahme LA, Washburn F, Alvarado-Ramy F
International Journal of Antimicrobial Agents
Extended spectrum of antibiotic susceptibility for tuberculosis, Djibouti
Feriel Bouzid, Michel Drancourt
High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan
Jung-Yien Chien, Po-Ren Hsueh
Journal of Global Antimicrobial Resistance
Antimicrobial resistance and the current refugee crisis
Helena C. Maltezou, Maria Theodoridou, George L. Daikos
Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years
Parvaneh Baghaei, Payam Tabarsi, Afshin Moniri, Majid Marjani, Parissa Farnia, Sayena Jabbehdari, Ali Akbar Velayati
The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs
Christine Sekaggya-Wiltshire, Mohammed Lamorde, Agnes N.Kiragga, Kelly E.Dooley, Moses R.Kamya, Andrew Kambugu, Jan Fehr, Yukari C.Manabe, Barbara Castelnuovo
Mycobacterial nucleoid associated proteins: An added dimension in gene regulation
Nastassja L.Kriel, James Gallant, Niëlvan Wyk, Paul van Helden, Samantha L.Sampson, Robin M.Warren, Monique J.Williams
Host genetics in susceptibility to and severity of mycobacterial diseases
A.S.Apt, N.N.Logunova, T.K.Kondratieva
MmpS5/MmpL5 as an efflux pump in Mycobacterium species
Julien Briffotaux, Wei Huang, Xinwei Wanga, Brigitte Gicquel
Journal of Hospital Infection
Investigation of a pre-XDR Beijing Mycobacterium tuberculosis transmission to a healthcare worker in France, 2016
A.Appelgren, D.Morquin, S.Dufour, V.Le Moing, J.Reynes, A.Lotthé, S.Parer, C.Corbeau, A.Aubry, W.Sougakoff, J.Solassol, L.Bonzon, Y.Dumont, S.Godreuil
Application of water-soluble nanofilters for collection of airborne Mycobacterium tuberculosis DNA in hospital wards
M.A.Vladimirsky, L.K.Shipina, E.S.Makeeva, Y.S.Alyapkina, A.Y.Mikheev, V.N.Morozov
Outbreak of tuberculosis in a closed setting: views on transmission based on results from molecular and conventional methods
E.Antusheva, O.Mironuk, I.Tarasova, P.Eliseev, G.Plusnina, M.Ridell, L.-O.Larsson, A.Mariyandyshev
Diabetes Research and Clinical Practice
Diabetes mellitus increased all-cause mortality rate among newly-diagnosed tuberculosis patients in an Asian population: A nationwide population-based study
Po-Yen Ko, Shi-Dou Lin, Ming-Chia Hsieh, Yu-Cheng Chen
The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting
Natacha Berkowitz, Adaeze Okorie, Rene Goliath, Naomi Levitt, Robert J.Wilkinson, Tolu Oni
Primary Care Diabetes
European Journal of Internal Medicine
American Journal of Infection Control
Hospital length of stay and cost burden of HIV, tuberculosis, and HIV-tuberculosis coinfection among pregnant women in the United States
Adeola Falana, Vanessa Akpojiyovwi, Esther Sey, Andika Akpaffiong, Olive Agumbah, Samara Chienye, Jamie Banks, Erin Jones, Kiara K.Spooner, Jason L.Salemi, Omonike A.Olaleye, Sherri D.Onyieg, Hamisu M.Salihu
Infection, Genetics and Evolution
The arms race between man and Mycobacterium tuberculosis: Time to regroup
Eileen G.Hoal, Anzaan Dippenaar, Craig Kinnear, Paul D.van Helden, Marlo Möller
Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
Huy Quang Nguyen, Nhung Viet Nguyen, Lucie Contamin, Thanh Hoa Thi Tran, Thuong Thi Vu, Hung Van Nguyen, Ngoc Lan Thi Nguyen, Son Thai Nguyen, Anh Duc Dang, Anne-Laure Bañuls, Van Anh Thi Nguyen
Microbes and Infection
Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis
Nira Pollock, Rakesh Dhiman, Nada Daifalla, Maha Farhat, Antonio Campos-Neto